INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 51 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $28,000 | -46.2% | 19,341 | 0.0% | 0.00% | -100.0% |
Q2 2017 | $52,000 | -33.3% | 19,341 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $78,000 | -3.7% | 19,341 | 0.0% | 0.00% | -50.0% |
Q4 2016 | $81,000 | -38.6% | 19,341 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $132,000 | +85.9% | 19,341 | +57.4% | 0.00% | 0.0% |
Q2 2016 | $71,000 | -2.7% | 12,291 | +17.1% | 0.00% | 0.0% |
Q1 2016 | $73,000 | -3.9% | 10,500 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $76,000 | -16.5% | 10,500 | 0.0% | 0.00% | -33.3% |
Q3 2015 | $91,000 | – | 10,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IMS Capital Management | 624,673 | $481,000 | 0.30% |
WEDBUSH SECURITIES INC | 98,255 | $76,000 | 0.01% |
Paulson Wealth Management Inc. | 11,250 | $9,000 | 0.01% |
Indiana Trust & Investment Management CO | 19,250 | $15,000 | 0.01% |
HYMAN CHARLES D | 30,000 | $23,000 | 0.00% |
Baker Brothers Advisors | 331,393 | $255,000 | 0.00% |
Virtu Financial LLC | 41,079 | $32,000 | 0.00% |
WELCH & FORBES LLC | 100,393 | $78,000 | 0.00% |
BOSTON FINANCIAL MANGEMENT LLC | 42,424 | $33,000 | 0.00% |
Valeo Financial Advisors, LLC | 5,750 | $4,000 | 0.00% |